WhitTier Trust Company’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.9K Buy
671
+406
+153% +$34.5K ﹤0.01% 728
2026
Q1
$23.5K Hold
265
﹤0.01% 873
2025
Q4
$24.7K Hold
265
﹤0.01% 863
2025
Q3
$16K Sell
265
-21
-7% -$1.21K ﹤0.01% 944
2025
Q2
$16.9K Hold
286
﹤0.01% 1037
2025
Q1
$20.9K Buy
286
+119
+71% +$9.83K ﹤0.01% 954
2024
Q4
$13.8K Buy
+167
New +$13.2K ﹤0.01% 1018

Other funds holding GMED

WhitTier Trust Company's GMED Position: Q2 2026 in Review

WhitTier Trust Company increased its Globus Medical (GMED) stake by 153% in Q2 2026, buying an estimated $34.5K and bringing the position to 671 shares worth $52.9K. The position accounts for ﹤0.01% of the portfolio, ranked #728.

WhitTier Trust Company first reported a position in GMED in Q4 2024 and has held it in 7 quarters since. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • WhitTier Trust Company held 671 shares of Globus Medical worth $52.9K as of Q2 2026.
  • WhitTier Trust Company bought 406 Globus Medical shares in Q2 2026, an estimated $34.5K.
  • Globus Medical made up ﹤0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #728 holding.
  • WhitTier Trust Company first reported a position in Globus Medical in Q4 2024 and has held it in 7 quarters since.
  • 600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.